Smart people in the industry have been quietly accumulating CUR for many many months. The potential for CUR still is not understood by the masses.
CUR can partner just as easily as INO did.
I agree, but as a biotech, the risk is still high. I'm holding 20,000 shares that I bought for an average of $1.65. I agree with you that it has unbelievable potential.
Sentiment: Strong Buy
Nice job, been sitting on 21,475 at cost basis of 1.26. 1 mill return would be nice, time will tell.
I think you could turn that investment into $1million or more. Just be patient.